Aveanna Healthcare (AVAH) reported $621.94 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 22.2%. EPS of $0.15 for the same period compares to $0.02 a year ago.
The reported revenue represents no surprise over the Zacks Consensus Estimate of $0 million. With the consensus EPS estimate being $0.08, the EPS surprise was +87.5%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Aveanna performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Hours - PDS: 11,822.00 hrs versus 11,102.22 hrs estimated by two analysts on average.
- Revenue rate - MS: $495.43 versus $489.43 estimated by two analysts on average.
- Unique patients served (UPS) - MS: 91 versus the two-analyst average estimate of 92.
- Revenue rate - PDS: $43.51 compared to the $42.62 average estimate based on two analysts.
- Revenue- PDS: $514.43 million versus the three-analyst average estimate of $473.17 million. The reported number represents a year-over-year change of +25.6%.
- Revenue- MS: $45.08 million versus the three-analyst average estimate of $44.63 million. The reported number represents a year-over-year change of -0.5%.
- Revenue- HHH: $62.43 million compared to the $59.35 million average estimate based on three analysts. The reported number represents a change of +15.3% year over year.
View all Key Company Metrics for Aveanna here>>>
Shares of Aveanna have returned +2.9% over the past month versus the Zacks S&P 500 composite's +1.3% change. The stock currently has a Zacks Rank #1 (Strong Buy), indicating that it could outperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Aveanna Healthcare Holdings Inc. (AVAH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
